ISO 22716:2007 - Cosmetics Good Manufacturing Practices (GMP) Internal Auditor Free Practice Test — 30 Questions

Question 1

During an internal audit of a cosmetic manufacturing facility, an auditor is reviewing the effectiveness of the complaint handling procedure. The company has received several customer feedback reports over the past quarter, ranging from minor packaging issues to concerns about product performance. The auditor needs to determine if the established system adequately addresses these issues and contributes to continuous improvement in product quality and GMP adherence. Which audit activity would most effectively validate the robustness and compliance of the complaint handling process with ISO 22716:2007?

Accepted Answer

Reviewing a selection of customer complaint files to verify the thoroughness of investigations, the identification of root causes, the implementation of corrective and preventive actions, and the correlation with production and quality control records.

Question 2

During an internal audit of a cosmetic manufacturing facility, an auditor observes that a cleaning crew used a non-validated disinfectant for a critical piece of mixing equipment between batches of different skincare formulations. The company\'s Standard Operating Procedure (SOP) for equipment cleaning specifies the use of only validated cleaning agents and provides a list of approved disinfectants. The auditor needs to determine the most appropriate course of action to ensure compliance with ISO 22716:2007 and protect product integrity.

Accepted Answer

Document the deviation from the SOP, investigate the reasons for using the unapproved disinfectant, assess its potential impact on product quality and safety, and recommend corrective actions to prevent recurrence.

Question 3

During an internal audit of a cosmetic manufacturing facility, an auditor is reviewing the process for managing customer feedback. The company has a documented procedure for handling complaints, which includes logging, investigating, and responding to customer concerns. However, the auditor observes that while complaints are logged and responses are issued, there is no clear evidence of systematic analysis of complaint trends or the implementation of corrective and preventive actions (CAPA) directly linked to recurring issues identified through this feedback. What is the most critical deficiency the auditor should identify regarding the company\'s adherence to ISO 22716:2007 principles for internal auditing and complaint management?

Accepted Answer

Inadequate verification of the effectiveness of the complaint handling system in driving product quality improvements and preventing recurrence of issues.

Question 4

When conducting an internal audit of a cosmetic manufacturer\'s compliance with ISO 22716:2007, what is the most critical aspect for an auditor to verify regarding the company\'s engagement with external laboratories for product safety and stability testing?

Accepted Answer

The existence and effective implementation of a documented process for selecting, evaluating, and monitoring external testing laboratories to ensure their adherence to relevant quality standards and regulatory requirements.

Question 5

During an internal audit of a cosmetic manufacturer\'s quality management system, an auditor is reviewing the process for handling customer feedback. The company has documented procedures for logging complaints, acknowledging receipt, and initiating investigations. However, the auditor needs to determine the effectiveness of this system in preventing future product-related issues. Which audit approach would most accurately assess the system\'s adherence to ISO 22716:2007 principles for continuous improvement and consumer safety?

Accepted Answer

Verifying that customer complaints are systematically investigated, root causes are identified, and documented corrective and preventive actions (CAPA) are implemented and their effectiveness confirmed.

Question 6

During an internal audit of a cosmetic manufacturing facility, an auditor discovers that several finished product batches were released without the required secondary quality control checks being documented in the batch release documentation. The Quality Assurance department has initiated a corrective action plan, which includes retraining personnel on documentation procedures and implementing a new electronic sign-off system for secondary checks. What is the most critical action for the internal auditor to undertake to verify the effectiveness of this corrective action plan?

Accepted Answer

Review a statistically significant sample of batch release documentation from the period following the CAPA implementation to confirm consistent and correct completion of secondary checks and associated electronic sign-offs.

Question 7

During an internal audit of \"AuraGlow Cosmetics,\" an auditor meticulously examines the raw material receiving and storage procedures. They discover a batch of \"Hyaluronic Acid Concentrate\" (Lot #HA7890) stored in the designated raw material warehouse. The packaging is intact, and the Certificate of Analysis is readily available and appears satisfactory. However, this batch is positioned on a pallet directly beside a pallet containing \"Industrial Degreaser X\" (Lot #DG1234), which is awaiting disposal. The area is generally clean, but a faint, non-cosmetic odor is detectable in the immediate vicinity of both pallets. What is the most appropriate classification for this observation according to ISO 22716:2007 principles for an internal auditor?

Accepted Answer

Minor Non-Conformity

Question 8

During an internal audit of a cosmetic manufacturer\'s facility, an auditor discovers a batch of finished facial serums that, due to a minor deviation in the filling process, have slightly inconsistent fill volumes. The quality assurance manager suggests that instead of segregating and evaluating the batch according to the established non-conforming product procedure, they will simply adjust the labeling to indicate a slightly lower net content for the affected units, thereby avoiding a formal write-off and associated documentation. What is the most appropriate action for the internal auditor to recommend in this situation to ensure compliance with ISO 22716:2007?

Accepted Answer

Insist that the batch be segregated, formally evaluated for its conformity to specifications, and a documented disposition be determined by authorized personnel, adhering strictly to the non-conforming product procedure.

Question 9

During an internal audit of a cosmetic manufacturer\'s quality management system, an auditor reviews a customer complaint concerning an unusual odor detected in a specific batch of facial serum. The company\'s records indicate that the complaint was acknowledged, and a replacement product was sent to the customer. However, the auditor finds no documented evidence of a root cause analysis for the odor or any verification that corrective actions, if any were taken, have effectively prevented recurrence. What is the most significant finding for the internal auditor in this scenario, according to the principles of ISO 22716:2007?

Accepted Answer

Lack of documented evidence confirming the thoroughness of the root cause investigation and the verification of corrective action effectiveness for the reported odor issue.

Question 10

During an internal audit of a cosmetic manufacturing facility, an auditor discovers a batch of finished skincare serum that exhibits a slight but measurable deviation from the approved viscosity specification. The batch has already been released for distribution. What is the auditor\'s primary responsibility in this scenario to ensure compliance with ISO 22716:2007 principles regarding non-conforming products?

Accepted Answer

Verify that the company has a documented procedure for handling non-conforming products and confirm that the disposition of this specific batch was executed in accordance with that procedure, including any necessary corrective actions and final disposition, to prevent its market release.

Question 11

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor reviews the procurement and receiving processes. The company purchases several key raw materials and packaging components from various external suppliers. While the company maintains a list of approved suppliers and has purchase orders detailing specifications, the auditor observes that there is no consistent, documented procedure for verifying that each incoming batch of materials actually conforms to these specifications before it is released for production. The auditor notes that the receiving department primarily relies on the supplier\'s accompanying documentation without independent verification.

What is the most significant finding an internal auditor should document in this scenario, based on the principles of ISO 22716:2007?

Accepted Answer

The absence of a documented procedure for verifying the conformity of incoming raw materials and packaging components against established specifications.

Question 12

During an internal audit of a cosmetic manufacturing facility, an auditor identified a non-conformity regarding the inadequate segregation of rejected raw materials. The auditee provided documentation showing that the rejected materials were moved to a designated holding area. In a subsequent follow-up audit, what is the primary focus for the internal auditor to assess the effectiveness of the corrective action?

Accepted Answer

Verification that the implemented segregation procedure has demonstrably prevented the inadvertent use or mixing of rejected raw materials with acceptable stock.

Question 13

During an internal audit of a cosmetic manufacturer\'s compliance with ISO 22716:2007, an auditor discovers that a critical raw material supplier, responsible for a key ingredient in a popular skincare line, recently experienced a significant batch contamination event. The manufacturer states they are aware of the issue and are \"managing it.\" What is the most crucial action for the internal auditor to undertake to assess the effectiveness of the company\'s quality management system in this context?

Accepted Answer

Review the company's documented procedures for supplier qualification and monitoring, and verify their application in response to the identified quality issue with the raw material supplier.

Question 14

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, what is the most critical evidence an auditor must seek to confirm the effective implementation of controls over product conformity to specifications?

Accepted Answer

Documented proof that incoming raw materials and outgoing finished products have been tested and confirmed to meet their respective quality specifications.

Question 15

An internal auditor is reviewing the production records for a batch of \"Aura Glow Serum\" that was subsequently identified as having a quality defect. The investigation reveals that while the finished product batch record lists the raw materials used, it does not explicitly cross-reference the specific lot numbers of critical ingredients such as \"Hyaluronic Acid Complex\" and \"Vitamin C Ester\" that were incorporated into that particular batch. The auditor notes that the raw material inventory system tracks individual lots, but the production batch compilation process does not systematically link these specific raw material lots to the finished product batch number in the final documentation. What is the most accurate assessment of this situation concerning ISO 22716:2007 requirements for GMP internal auditing?

Accepted Answer

The batch records failed to ensure full traceability of raw materials to the finished product.

Question 16

During an internal audit of a cosmetic manufacturing facility, an auditor is tasked with evaluating the effectiveness of the personnel training and hygiene program as per ISO 22716:2007. The company has documented comprehensive training modules on handwashing, gowning procedures, and cross-contamination prevention, and these are readily available. However, the auditor observes that several production staff members in the compounding area are not consistently wearing hairnets correctly, and a review of recent training records shows a gap in refresher training for a significant portion of the night shift team. Which of the following audit findings would most accurately reflect a potential non-conformity related to the personnel requirements of the standard?

Accepted Answer

Inadequate implementation of documented personnel hygiene and training protocols, evidenced by inconsistent adherence to gowning procedures and a documented lapse in refresher training for a specific shift.

Question 17

During an internal audit of a cosmetic manufacturing facility, an auditor reviews the complaint handling process. A customer reported a mild skin irritation after using a newly launched facial serum. The investigation records indicate that the complaint was logged, and a batch analysis of the serum was performed, which showed no deviations from specifications. However, the investigation report lacks a detailed root cause analysis beyond the batch conformity and does not document any specific corrective or preventive actions taken to address the customer\'s experience or to prevent recurrence of similar issues, even if the batch was compliant. What is the most significant finding for the internal auditor in this scenario regarding compliance with ISO 22716:2007?

Accepted Answer

The investigation failed to establish a clear root cause and lacked documented corrective and preventive actions.

Question 18

During an internal audit of a cosmetic manufacturer\'s compliance with ISO 22716:2007, an auditor observes that a batch of raw material, identified as having slightly higher viscosity than specified, was released for production after a brief discussion between the production manager and the quality control supervisor. The auditor\'s primary concern should be to verify which of the following regarding the handling of this deviation?

Accepted Answer

The existence and thoroughness of documented procedures for identifying, investigating, and dispositioning non-conforming raw materials, and evidence of their consistent application.

Question 19

During an internal audit of a cosmetic manufacturing facility, an auditor discovers that a batch of finished skincare serum was released to the market. However, records indicate that a critical ingredient, Glycerin USP, was used in its production despite the absence of a complete and verified Certificate of Analysis (CoA) at the time of its incorporation into the batch. The company\'s deviation management procedure requires that any use of raw materials without a complete CoA must be formally documented, a risk assessment conducted, and approval obtained from the Quality Assurance Manager before proceeding. The auditor finds that while the deviation was noted, the risk assessment was superficial, and the Quality Assurance Manager\'s approval was not explicitly documented for this specific instance. What is the most appropriate action for the internal auditor to take regarding this finding?

Accepted Answer

Recommend a thorough review of the deviation management process, including the adequacy of risk assessments and the documented approval for the use of raw materials without complete documentation, and verify the implementation of any corrective actions taken by the company.

Question 20

During an internal audit of a cosmetic manufacturing facility, an auditor reviews the customer feedback log and discovers a pattern of three distinct complaints within a two-week period regarding a specific batch of a facial serum. The complaints uniformly describe an unusual, mild tingling sensation experienced shortly after application, which was not previously reported for this product. The production manager states that the batch in question was manufactured using the standard approved process and raw materials. What is the most appropriate finding for the internal auditor to document regarding the company\'s handling of this situation, based on the principles of ISO 22716:2007?

Accepted Answer

The company has initiated a root cause analysis for the reported tingling sensation and is in the process of developing corrective actions to address potential issues with the specific batch or its manufacturing process.

Question 21

During an internal audit of a cosmetic manufacturer adhering to ISO 22716:2007, an auditor is assessing the controls over outsourced manufacturing processes. The company utilizes a third-party facility for the final filling and packaging of several product lines. What is the primary focus for the auditor when verifying the effectiveness of the company\'s management of this external service provider?

Accepted Answer

Reviewing the documented procedures for selecting, evaluating, and monitoring the external service provider to ensure their compliance with ISO 22716:2007 requirements.

Question 22

During an internal audit of a cosmetic manufacturing facility, an auditor discovers a documented deviation in the filling process for a high-volume facial serum. The deviation report indicates that several batches experienced an underfill of approximately 5% of the specified volume. The company\'s corrective action plan, as documented, focuses solely on recalibrating the filling machinery and retraining operators on standard operating procedures. However, the plan does not include any investigation into the systemic factors that may have contributed to the underfill, nor does it detail any assessment of the potential impact on batches already released to the market. What is the most appropriate conclusion for the internal auditor to draw regarding the company\'s management of this non-conformity in accordance with ISO 22716:2007 principles?

Accepted Answer

The corrective action plan is insufficient as it fails to adequately address root cause analysis and assess the potential impact on previously distributed products.

Question 23

During an internal audit of a cosmetic manufacturing facility, an auditor discovers that a batch of finished product was released for sale despite using a raw material from a supplier not listed on the approved vendor list. The company\'s quality manager states that the raw material was of equivalent quality and was used to avoid production delays. What is the auditor\'s primary responsibility in this situation according to ISO 22716:2007 principles for internal audits?

Accepted Answer

Verify that the company has a documented procedure for handling deviations and non-conformities, and that this procedure was followed to assess the impact of the deviation and initiate corrective actions.

Question 24

During an internal audit of a cosmetic manufacturing facility, it was discovered that a critical raw material, Batch XYZ-789, used in the production of several skincare formulations, was subsequently found to be non-conforming due to an out-of-specification microbial count. This non-conformance was identified after the raw material had already been incorporated into multiple finished product batches. What is the immediate and most critical action the Quality Assurance department must undertake to ensure compliance with ISO 22716:2007 and protect consumer safety?

Accepted Answer

Immediately identify and quarantine all finished product batches that incorporated raw material Batch XYZ-789.

Question 25

During an internal audit of a cosmetic manufacturing facility, a critical raw material used in a popular facial serum is found to have a significant deviation from its specified purity levels, discovered through post-market surveillance. The auditor needs to assess the effectiveness of the company\'s recall readiness. Which of the following actions by the auditor would most critically evaluate the company\'s ability to manage this specific recall scenario, considering the ingredient defect?

Accepted Answer

Verifying the precise identification of all finished product batches that incorporated the affected raw material and their corresponding distribution records.

Question 26

An internal auditor conducting a routine check of a cosmetic manufacturing facility discovers a significant quantity of finished facial serum packaged in bottles with incorrect ingredient lists displayed on the labels. These units have been moved to the dispatch area and are awaiting shipment to various retail partners. What is the most critical immediate action the auditor should recommend to the Quality Assurance Manager to ensure compliance with GMP principles?

Accepted Answer

Immediately segregate the non-conforming batch of facial serum and initiate a documented investigation into the root cause of the labeling error to determine appropriate disposition.

Question 27

During an internal audit of a cosmetic manufacturing facility, an auditor observes that the documented procedure for raw material sampling, which mandates the collection of five distinct samples from each incoming batch for quality control testing, is consistently being followed by taking only three samples. The company\'s quality manager asserts that their internal risk assessment indicates that three samples are statistically sufficient for their current supplier reliability. What is the primary focus of the auditor\'s evaluation in this situation, considering the requirements of ISO 22716:2007?

Accepted Answer

Determining if the deviation from the documented procedure poses an unacceptable risk to product quality and consumer safety, and if the company's rationale for the deviation is adequately supported and integrated into their QMS.

Question 28

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor is reviewing the process for incoming raw materials. The company\'s quality manual outlines procedures for supplier qualification and material inspection upon receipt. However, the auditor observes that a batch of a critical botanical extract, designated for a sensitive skincare product, is stored in a general-purpose area without clear segregation from non-approved materials. Furthermore, the accompanying certificate of analysis (CoA) for this specific batch appears to be missing from the immediate receiving documentation, though it is reportedly filed elsewhere in the quality department.

Which of the following auditor conclusions most accurately reflects a potential non-conformity with ISO 22716:2007 principles regarding raw material control and traceability?

Accepted Answer

The auditor should conclude that the lack of immediate segregation and readily accessible CoA for the botanical extract batch indicates a potential breakdown in the raw material receiving and identification process, compromising traceability and adherence to GMP.

Question 29

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor discovers a batch of foundation with inconsistent color pigmentation. The batch record indicates a deviation from the standard mixing procedure, which was documented and investigated. What is the most critical aspect for the auditor to verify to ensure the effectiveness of the company\'s deviation management process?

Accepted Answer

The thoroughness of the root cause analysis and the documented corrective and preventive actions implemented to prevent recurrence.

Question 30

During an internal audit of a cosmetic manufacturing facility, an auditor is reviewing the process for handling incoming raw materials and packaging components. The facility produces a range of skincare products. The auditor needs to ascertain the effectiveness of the controls in place to prevent the use of non-conforming or incorrect materials in production. What is the most critical control point for the internal auditor to verify in this context, ensuring adherence to ISO 22716:2007 principles?

Accepted Answer

Verification of a documented procedure for the reception, identification, inspection, and release of raw materials and packaging components by authorized personnel.

ISO 22716:2007 - Cosmetics Good Manufacturing Practices (GMP) Internal Auditor Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 22716:2007 - Cosmetics Good Manufacturing Practices (GMP) Internal Auditor Certification